International Patent: PROSTATE-SPECIFIC MEMBRANE ANTIGEN INHIBITOR, RADIONUCLIDE MARKER THEREOF, AND USE THEREOF

GENEVA, July 1 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/142248) for “PROSTATE-SPECIFIC MEMBRANE ANTIGEN INHIBITOR, RADIONUCLIDE MARKER THEREOF, AND USE THEREOF”. With publication no. WO/2026/124661, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 257/02

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....